tiprankstipranks
Medtronic (MDT)
NYSE:MDT
US Market
MDT
Medtronic
RESEARCH TOOLSreports
Want to see MDT full AI Analyst Report?

Medtronic (MDT) Stock Forecast & Price Target

6,537 Followers
See the Price Targets and Ratings of:

MDT Analyst Ratings

Moderate Buy
19Ratings
Moderate Buy
12 Buy
7 Hold
0 Sell
Based on 19 analysts giving stock ratings to
Medtronic
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MDT Stock 12 Month Forecast

Average Price Target

$101.94
▲(18.27% Upside)
Based on 19 Wall Street analysts offering 12 month price targets for Medtronic in the last 3 months. The average price target is $101.94 with a high forecast of $120.00 and a low forecast of $80.00. The average price target represents a 18.27% change from the last price of $86.19.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"72":"$72","121":"$121","84.25":"$84.3","96.5":"$96.5","108.75":"$108.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":120,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$120.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":101.94117647058823,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$101.94</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":80,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$80.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[72,84.25,96.5,108.75,121],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,73.98,77.52000000000001,81.06,84.60000000000001,88.14,91.68,95.22,98.76,102.3,105.84,109.38,112.92,116.46000000000001,{"y":120,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,73.98,76.13085972850679,78.28171945701358,80.43257918552037,82.58343891402716,84.73429864253394,86.88515837104073,89.0360180995475,91.18687782805429,93.33773755656108,95.48859728506787,97.63945701357466,99.79031674208144,{"y":101.94117647058823,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,73.98,74.44307692307693,74.90615384615386,75.36923076923077,75.8323076923077,76.29538461538462,76.75846153846155,77.22153846153846,77.68461538461538,78.14769230769231,78.61076923076924,79.07384615384615,79.53692307692307,{"y":80,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":81.16,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":86.73,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 45,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87.307,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 46,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":90.698,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":93.355,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":89.308,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":101.754,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":95.282,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":101.878,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":97.305,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":86.06,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.98,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$120.00Average Price Target$101.94Lowest Price Target$80.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Mizuho Securities Analyst forecast on MDT
Anthony Petrone
Mizuho Securities
Mizuho Securities
$120→$100
Buy
16.02%
Upside
Reiterated
06/03/26
Mizuho cuts Medtronic target, sees recent selloff as overdoneMizuho cuts Medtronic target, sees recent selloff as overdone
Needham Analyst forecast on MDT
Michael Matson
Needham
Needham
$120→$101
Buy
17.18%
Upside
Reiterated
06/03/26
Medtronic Maintained at Buy as Product Momentum Offsets Valuation Concerns Despite Price Target Cut to $101
BTIG Analyst forecast on MDT
Ryan Zimmerman
BTIG
BTIG
$90
Buy
4.42%
Upside
Upgraded
06/03/26
Medtronic upgraded to Buy from Neutral at BTIGMedtronic upgraded to Buy from Neutral at BTIG
Stifel Nicolaus Analyst forecast on MDT
Rick Wise
Stifel Nicolaus
Stifel Nicolaus
$95→$80
Hold
-7.18%
Downside
Reiterated
06/03/26
Medtronic price target lowered to $80 from $95 at StifelMedtronic price target lowered to $80 from $95 at Stifel
William Blair Analyst forecast on MDT
Brandon Vazquez
William Blair
William Blair
―
Buy
―
Reiterated
06/03/26
Analyst Maintains Buy on Medtronic as Innovation Pipeline and Robotic Surgery Momentum Offset 2027 Cost Headwinds
Bank of America Securities Analyst forecast on MDT
Travis Steed
Bank of America Securities
Bank of America Securities
$110
Buy
27.63%
Upside
Reiterated
06/02/26
Medtronic: Buy Rating Reiterated as Diverse Growth Engines Offset Hugo Challenges; $110 Price Target Maintained
Truist Financial Analyst forecast on MDT
Richard Newitter
Truist Financial
Truist Financial
―
Hold
―
Reiterated
05/21/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Medtronic (NYSE: MDT), Immunovant (NASDAQ: IMVT) and Anteris Technologies Global Corp. (NASDAQ: AVR)
Wells Fargo Analyst forecast on MDT
Larry Biegelsen
Wells Fargo
Wells Fargo
$114
Buy
32.27%
Upside
Reiterated
05/21/26
Wells Fargo Sticks to Its Buy Rating for Medtronic (MDT)
Goldman Sachs Analyst forecast on MDT
David Roman
Goldman Sachs
Goldman Sachs
$84
Hold
-2.54%
Downside
Initiated
05/21/26
Medtronic (MDT) Initiated with a Hold at Goldman Sachs
TD Cowen Analyst forecast on MDT
Josh Jennings
TD Cowen
TD Cowen
$119
Buy
38.07%
Upside
Reiterated
05/20/26
Analysts Are Bullish on Top Healthcare Stocks: Medtronic (MDT), Vyome Holdings (HIND)
Piper Sandler Analyst forecast on MDT
Matthew O'Brien
Piper Sandler
Piper Sandler
$91
Hold
5.58%
Upside
Reiterated
05/19/26
Piper Sandler Sticks to Their Hold Rating for Medtronic (MDT)
Citi Analyst forecast on MDT
Joanne Wuensch
Citi
Citi
$107→$110
Buy
27.63%
Upside
Reiterated
04/26/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Medtronic (NYSE: MDT), Neogen (NASDAQ: NEOG) and Community Health (NYSE: CYH)
Jefferies Analyst forecast on MDT
Matthew Taylor
Jefferies
Jefferies
$95
Hold
10.22%
Upside
Assigned
04/24/26
Medtronic: Portfolio Streamlining and Diabetes Spin-Off Benefits Offset by Lower Growth Outlook and Valuation Compression, Justifying Hold Rating
UBS Analyst forecast on MDT
Priya Sachdeva
UBS
UBS
$104→$90
Hold
4.42%
Upside
Assigned
04/22/26
Medtronic price target lowered to $90 from $104 at UBSMedtronic price target lowered to $90 from $104 at UBS
RBC Capital Analyst forecast on MDT
Shagun Singh Chadha
RBC Capital
RBC Capital
$118
Buy
36.91%
Upside
Reiterated
04/13/26
RBC Capital Sticks to Their Buy Rating for Medtronic (MDT)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Mizuho Securities Analyst forecast on MDT
Anthony Petrone
Mizuho Securities
Mizuho Securities
$120→$100
Buy
16.02%
Upside
Reiterated
06/03/26
Mizuho cuts Medtronic target, sees recent selloff as overdoneMizuho cuts Medtronic target, sees recent selloff as overdone
Needham Analyst forecast on MDT
Michael Matson
Needham
Needham
$120→$101
Buy
17.18%
Upside
Reiterated
06/03/26
Medtronic Maintained at Buy as Product Momentum Offsets Valuation Concerns Despite Price Target Cut to $101
BTIG Analyst forecast on MDT
Ryan Zimmerman
BTIG
BTIG
$90
Buy
4.42%
Upside
Upgraded
06/03/26
Medtronic upgraded to Buy from Neutral at BTIGMedtronic upgraded to Buy from Neutral at BTIG
Stifel Nicolaus Analyst forecast on MDT
Rick Wise
Stifel Nicolaus
Stifel Nicolaus
$95→$80
Hold
-7.18%
Downside
Reiterated
06/03/26
Medtronic price target lowered to $80 from $95 at StifelMedtronic price target lowered to $80 from $95 at Stifel
William Blair Analyst forecast on MDT
Brandon Vazquez
William Blair
William Blair
―
Buy
―
Reiterated
06/03/26
Analyst Maintains Buy on Medtronic as Innovation Pipeline and Robotic Surgery Momentum Offset 2027 Cost Headwinds
Bank of America Securities Analyst forecast on MDT
Travis Steed
Bank of America Securities
Bank of America Securities
$110
Buy
27.63%
Upside
Reiterated
06/02/26
Medtronic: Buy Rating Reiterated as Diverse Growth Engines Offset Hugo Challenges; $110 Price Target Maintained
Truist Financial Analyst forecast on MDT
Richard Newitter
Truist Financial
Truist Financial
―
Hold
―
Reiterated
05/21/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Medtronic (NYSE: MDT), Immunovant (NASDAQ: IMVT) and Anteris Technologies Global Corp. (NASDAQ: AVR)
Wells Fargo Analyst forecast on MDT
Larry Biegelsen
Wells Fargo
Wells Fargo
$114
Buy
32.27%
Upside
Reiterated
05/21/26
Wells Fargo Sticks to Its Buy Rating for Medtronic (MDT)
Goldman Sachs Analyst forecast on MDT
David Roman
Goldman Sachs
Goldman Sachs
$84
Hold
-2.54%
Downside
Initiated
05/21/26
Medtronic (MDT) Initiated with a Hold at Goldman Sachs
TD Cowen Analyst forecast on MDT
Josh Jennings
TD Cowen
TD Cowen
$119
Buy
38.07%
Upside
Reiterated
05/20/26
Analysts Are Bullish on Top Healthcare Stocks: Medtronic (MDT), Vyome Holdings (HIND)
Piper Sandler Analyst forecast on MDT
Matthew O'Brien
Piper Sandler
Piper Sandler
$91
Hold
5.58%
Upside
Reiterated
05/19/26
Piper Sandler Sticks to Their Hold Rating for Medtronic (MDT)
Citi Analyst forecast on MDT
Joanne Wuensch
Citi
Citi
$107→$110
Buy
27.63%
Upside
Reiterated
04/26/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Medtronic (NYSE: MDT), Neogen (NASDAQ: NEOG) and Community Health (NYSE: CYH)
Jefferies Analyst forecast on MDT
Matthew Taylor
Jefferies
Jefferies
$95
Hold
10.22%
Upside
Assigned
04/24/26
Medtronic: Portfolio Streamlining and Diabetes Spin-Off Benefits Offset by Lower Growth Outlook and Valuation Compression, Justifying Hold Rating
UBS Analyst forecast on MDT
Priya Sachdeva
UBS
UBS
$104→$90
Hold
4.42%
Upside
Assigned
04/22/26
Medtronic price target lowered to $90 from $104 at UBSMedtronic price target lowered to $90 from $104 at UBS
RBC Capital Analyst forecast on MDT
Shagun Singh Chadha
RBC Capital
RBC Capital
$118
Buy
36.91%
Upside
Reiterated
04/13/26
RBC Capital Sticks to Their Buy Rating for Medtronic (MDT)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Medtronic

3 Months
Anthony PetroneMizuho Securities
Success Rate
17/24 ratings generated profit
71%
Average Return
+2.66%
Copying Anthony Petrone's trades and holding each position for 3 Months would result in 70.83% of your transactions generating a profit, with an average return of +2.66% per trade.
1 Year
Anthony PetroneMizuho Securities
Success Rate
15/24 ratings generated profit
63%
Average Return
-1.21%
Copying Anthony Petrone's trades and holding each position for 1 Year would result in 62.50% of your transactions generating a profit, with an average return of -1.21% per trade.
2 Years
Vijay KumarEvercore ISI
Success Rate
10/18 ratings generated profit
56%
Average Return
+4.05%
Copying Vijay Kumar's trades and holding each position for 2 Years would result in 55.56% of your transactions generating a profit, with an average return of +4.05% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MDT Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
0
0
0
2
2
Buy
30
33
36
24
19
Hold
20
14
18
12
11
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
50
47
54
38
32
In the current month, MDT has received 21 Buy Ratings, 11 Hold Ratings, and 0 Sell Ratings. MDT average Analyst price target in the past 3 months is 101.94.
Each month's total comprises the sum of three months' worth of ratings.

MDT Financial Forecast

MDT Earnings Forecast

Next quarter’s earnings estimate for MDT is $1.39 with a range of $1.32 to $1.53. The previous quarter’s EPS was $1.55. MDT beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year MDT has Performed in-line its overall industry.
Next quarter’s earnings estimate for MDT is $1.39 with a range of $1.32 to $1.53. The previous quarter’s EPS was $1.55. MDT beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year MDT has Performed in-line its overall industry.

MDT Sales Forecast

Next quarter’s sales forecast for MDT is $9.44B with a range of $9.02B to $9.84B. The previous quarter’s sales results were $9.81B. MDT beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year MDT has Performed in-line its overall industry.
Next quarter’s sales forecast for MDT is $9.44B with a range of $9.02B to $9.84B. The previous quarter’s sales results were $9.81B. MDT beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year MDT has Performed in-line its overall industry.

MDT Stock Forecast FAQ

What is MDT’s average 12-month price target, according to analysts?
Based on analyst ratings, Medtronic’s 12-month average price target is 101.94.
    What is MDT’s upside potential, based on the analysts’ average price target?
    Medtronic has 18.27% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is MDT a Buy, Sell or Hold?
          Medtronic has a consensus rating of Moderate Buy which is based on 12 buy ratings, 7 hold ratings and 0 sell ratings.
            What is Medtronic’s price target?
            The average price target for Medtronic is 101.94. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $120.00 ,the lowest forecast is $80.00. The average price target represents 18.27% Increase from the current price of $86.19.
              What do analysts say about Medtronic?
              Medtronic’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 19 Wall Streets Analysts.
                How can I buy shares of MDT?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.